Protein FGL2 may have potential as therapy target for brain cancer
5/18/2015
Blocking FGL2, a protein known to promote cancer, may offer a new strategy for treating brain cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Research shows how antibodies produce vaccine-like effect against tumors
5/18/2015
Two antibody-binding receptors on immune cells are key to killing tumors and creating a memory of themKnown as the Fc domain, the stem of Y-shaped antibodies (above) can activate immune cells...
No link found between PTSD and cancer risk
5/18/2015
In the largest study to date that examines Post Traumatic Stress Disorder (PTSD) as a risk factor for cancer, researchers from Boston University School of Medicine (BUSM), have shown no evidence of...
Cancer survivors have evolving information needs
5/18/2015
Judging by the nature and topics of their information seeking, cancer patients' information needs appear to differ depending on the type of cancer they have and where they are in their survivorship.
Moffitt researchers say androgen deprivation therapy may lead to cognitive impairment
5/16/2015
Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy.
Starving cancer cells instead of feeding them poison
5/16/2015
Simulation offers hope of killing cancers without sickening patientsA patent application for a drug that could destroy the deadly childhood disease known as acute lymphoblastic leukemia -- and...
Drug extends survival of patients with metastatic colorectal cancer
5/16/2015
Lengthens survival and slows progress of disease in patients who no longer respond to other treatments Taken in pill form, the drug produces few side effectsA drug developed 50 years ago...
Fee-for-service health care may lead to higher risk for robotic prostate surgery patients
5/15/2015
A "perverse disincentive" for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study...
Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer
5/15/2015
Additional data show Prolaris changed treatment plans in 48 percent of casesMyriad Genetics, Inc.
Research finds DNA damage caused by smoking can be detected in cheek swabs
5/15/2015
DNA damage caused by smoking can be detected in cheek swabs, finds research published in JAMA Oncology.